Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not
pursue another term in office - Supervisory Board expresses great regret

EQS-News: SARTORIUS AG / Key word(s): Personnel
Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not
pursue another term in office - Supervisory Board expresses great regret
(news with additional features)

02.07.2024 / 10:53 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Göttingen, July 2, 2024

Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not
pursue another term in office - Supervisory Board expresses great regret

The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed
the company's Supervisory Board that after more than 20 years as CEO of the
company, he will not be seeking another extension of his current contract
when it expires in November 2025. The Supervisory Board has taken note of
Kreuzburg's decision with great regret.

Kreuzburg has been at the helm of the company since 2003. After joining
Sartorius AG in 1999, he was appointed to the Executive Board in 2002 at the
age of 37 and became Chairman a few months later. During this time,
Sartorius' sales revenue increased more than 7-fold to around 3.4 billion
euros and profits more than 26-fold to around 1 billion euros, the number of
employees quadrupled to over 14,000 while the Group's stock market valuation
increased from just over 90 million euros to more than 17 billion euros.

The Chairman of the Supervisory Board of Sartorius AG, Dr. Lothar Kappich,
said: "Sartorius owes Joachim Kreuzburg an extraordinary amount. With his
dynamic entrepreneurial qualities, he has transformed the company into an
internationally leading and particularly profitable life science group,
expanded the technology and product portfolio enormously and built up an
outstanding team. We very much regret his decision. At the same time, we
would like to thank him for informing us of his decision at an early stage
and for continuing to be available to Sartorius until November 2025. The
Supervisory Board will now initiate a succession process in an orderly and
careful manner. I look forward to continuing to work so closely and well
with Joachim Kreuzburg for another one and a half years until his
departure."

Kreuzburg said: "After so many years at the helm of this special company, I
would like to have more space and time for new topics and projects in the
future. For the upcoming phase of my life, I am ruling out taking on an
executive top role, while I will continue to be involved in my mandates in
business and science and will also engage in further business activities,
especially in such innovation-driven sectors as biotechnology and medicine.
After a phase of extraordinary growth, the entire life science industry is
facing temporary challenges in the current "post-pandemic phase", while the
prospects for the future remain excellent. The trough has been passed and I
will continue to fully focus on Sartorius over the next year and a half and,
together with my team, will work with all my energy to ensure that the
company continues to develop more innovatively, faster and more profitably
than the competition. At the same time, it was important to me to inform the
Supervisory Board of my plans at an early point so that they can prepare for
my succession without time pressure."



A profile of Sartorius
Sartorius (XETRA: SRT3 | STR) is a leading international partner of life
sciences research and the biopharmaceutical industry. With innovative
laboratory instruments and consumables, the Group's Lab Products & Services
division focuses on laboratories performing research and quality control at
pharmaceutical and biopharmaceutical companies as well as academic research
institutes. The Bioprocess Solutions division, with its broad product
portfolio focusing on single-use solutions, helps customers manufacture
biotech medications, vaccines, and cell and gene therapies safely, rapidly,
and economically. The company, based in Göttingen, Germany, has a strong
global reach with around 60 production and sales sites worldwide. Sartorius
regularly expands its portfolio through the acquisition of complementary
technologies. In 2023, the company generated sales revenue of around 3.4
billion euros. Currently, around 14,600 employees are working for customers
around the globe.

Visit our newsroom and follow Sartorius on LinkedIn.

Contact
Petra Kirchhoff
Head of Corporate Communications & Investor Relations
+49 (0)551.308.1686
petra.kirchhoff@sartorius.com


---------------------------------------------------------------------------

Additional features:

File: https://eqs-cockpit.com/c/fncls.ssp?u=10e319b0eb5e80387ff2c6b6e07b30f0
File description: 240702_Media Release_SAG_Contract CEO_en (1)

---------------------------------------------------------------------------

02.07.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        SARTORIUS AG
                   Otto-Brenner-Straße 20
                   37079 Göttingen
                   Germany
   Phone:          +49.(0)551-308.0
   Fax:            +49.(0)551-308.3289
   E-mail:         info@sartorius.com
   Internet:       www.sartorius.com
   ISIN:           DE0007165607, DE0007165631
   WKN:            716560 , 716563
   Indices:        DAX, TecDAX
   Listed:         Regulated Market in Frankfurt (Prime Standard),
                   Hanover; Regulated Unofficial Market in Berlin,
                   Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate
                   Exchange
   EQS News ID:    1937941

End of News EQS News Service
---------------------------------------------------------------------------

1937941 02.07.2024 CET/CEST